{"title": "Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2", "author": "Liangxia Ai; Yafei Li; Li Zhou; Hao Zhang; Wenrong Yao; Jinyu Han; Junmiao Wu; Ruiyue Wang; Weijie Wang; Pan Xu; Zhouwang Li; Chengliang Wei; Haobo Chen; Jianqun Liang; Ming Guo; Zhixiang Huang; Xin Wang; Zhen Zhang; Wenjie Xiang; Bin Lv; Peiqi Peng; Shangfeng Zhang; Xuhao Ji; Zhangyi Li; Huiyi Luo; Jianping Chen; Ke Lan; Yong Hu", "url": "https://www.biorxiv.org/content/10.1101/2022.02.10.479867v2", "hostname": "biorxiv.org", "description": "Advanced mRNA vaccines play vital roles against SARS-CoV-2. However, due to the poor stability, most current mRNA delivery platforms need to be stored at 20 \u00b0C or 70 \u00b0C. Here we present lyophilized thermostable mRNA loaded lipid nanoparticles, which could be stored at room temperature with long-term stability. We demonstrate the applicability of lyophilization techniques to different mRNA sequences and lipid components. Three lyophilized vaccines targeting wild-type, Delta and Omicron SARS-CoV-2 variant were prepared and demonstrated to be able induce high-level of IgG titer and neutralization response. In the Delta challenge in vivo experiment, the lyophilized mRNA vaccine successfully protected the mice from infection and clear the virus. This lyophilization platform could significantly improve the accessibility of mRNA vaccine or therapeutics, particularly in remote regions. ### Competing Interest Statement The authors have declared no competing interest.", "sitename": "Biorxiv", "date": "2022-02-11", "cleaned_text": "Abstract Advanced mRNA vaccines play vital roles against SARS-CoV-2. However, due to the poor stability, most current mRNA delivery platforms need to be stored at 20 \u00b0C or 70 \u00b0C. Here we present lyophilized thermostable mRNA loaded lipid nanoparticles, which could be stored at room temperature with long-term stability. We demonstrate the applicability of lyophilization techniques to different mRNA sequences and lipid components. Three lyophilized vaccines targeting wild-type, Delta and Omicron SARS-CoV-2 variant were prepared and demonstrated to be able induce high-level of IgG titer and neutralization response. In the Delta challenge in vivo experiment, the lyophilized mRNA vaccine successfully protected the mice from infection and clear the virus. This lyophilization platform could significantly improve the accessibility of mRNA vaccine or therapeutics, particularly in remote regions. Competing Interest Statement The authors have declared no competing interest. "}